Clinical Handbook of Psychotropic Drugs, 24th Edition (Original PDF

Clinical Handbook of Psychotropic Drugs, 24th Edition 2021 Original PDF

Please log in to view product prices.

AUTHORS: Ed. Procyshyn, Ric M.
Category:

Clinical Handbook of Psychotropic Drugs, 24th Edition 2021 Original PDF

New in this edition:

  • Neuroscience-based nomenclature – added to product availability tables
  • Antidepressants chapter includes new section on GABAA receptor positive modulator (brexanolone IV injection; trade name Zulresso)
  • Also covers Qelbree (viloxazine extended-release capsules), the first new ADHD medication approved by the FDA in over a decade; as well as updates to SSRI use in pregnancy and antidepressant augmentation strategies
  • Antipsychotics updates include revised dosing, especially adjustments in hepatic and renal impairment
  • Mood stabilisers chapter sections on lithium and anticonvulsants extensively revised
  • New formulations and trade names include: Adhansia XR (methylphenidate extended-release capsules), Caplyta (lumateperone), Dayvigo (lemborexant), Perseris (risperidone extended-release subcutaneous injection), Probuphine (buprenorphine subdermal implant), Propecia (finasteride tablets), Trelstar (triptorelin slow-release injection), Qelbree (viloxazine extended-release capsules), Zulresso (brexanolone IV injection)

AUTHORS: Ed. Procyshyn, Ric M.

PAGES: 432

YEAR: 2021

PUBLICATION: Hogrefe Publishing

LANGUAGE: English

Related Products